Donald Trump, MD, FACP

Donald Trump, MD, FACP

Roswell Park Cancer Institute
President and CEO
Professor
School of Medicine and Biomedical Sciences, State University of New York at Buffalo
Professor of Medicine and Pharmacology

Dr. Donald L. Trump was appointed President and Chief Executive Officer of Roswell Park Cancer Institute (RPCI) on April 1, 2007. On first coming to RPCI in January 2002, Dr. Trump served as Senior Vice President for Clinical Research; Chair, Department of Medicine; and Co-Principal Investigator (PI) of the Cancer Center Support Grant (CCSG) funded by the National Cancer Institute. He was appointed Associate Institute Director in the fall of 2006 and became President and CEO of RPCI, and PI of the CCSG, in 2007.

Dr. Trump has direct authority over day-to-day operations, philanthropic and operating budgets, capital improvements, research priorities and clinical and scientific strategic planning for the Institute. He is responsible for establishing a culture of excellence throughout RPCI’s key mission areas: research, clinical care, education and cancer prevention.

In addition to his role as President and CEO, Dr. Trump continues his work as a clinical scientist and physician. He leads the Institute’s strong clinical research program in vitamin D-based cancer prevention and treatment, and he cares for patients with prostate cancer and other urologic cancers. He is principal investigator or co-principal investigator on several grants funded by the National Cancer Institute. He holds European and U.S. patents for the use of vitamin D and vitamin D analogs in combination with high-dose chemotherapy.

Dr. Trump earned his medical degree from The Johns Hopkins University School of Medicine, Baltimore, MD, in 1970. From 1970 to 1975, he completed an internship and residency training in Medicine and a fellowship in Oncology and served as Chief Resident in Internal Medicine at The Johns Hopkins Hospital. Dr. Trump is a Diplomate of the American Board of Internal Medicine, with Subspecialty Boards in Medical Oncology, and a Fellow of the American College of Physicians.

Dr. Trump is past Secretary/Treasurer of the American Society of Clinical Oncology, and is a member of many professional and scientific societies. Together with his collaborator, Dr. Candace Johnson, Deputy Director of RPCI, Dr. Trump has co-edited a recent textbook entitled Vitamin D and Cancer (Springer). In May 2009 he was inducted into the Johns Hopkins University Society of Scholars. He is a reviewer and/or member of the editorial board of prestigious journals, such as the New England Journal of Medicine, Journal of the National Cancer Institute, Cancer, Journal of Urologic Oncology, Clinical Cancer Research, Cure, Oncology, American Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Cancer Research, and Journal of Clinical Oncology. Dr. Trump has authored or co-authored more than 200 journal publications, book chapters and abstracts.

Areas of Expertise: 
Bladder Cancer
Kidney Cancer
Prostate Cancer
Testicular Cancer
Special Interests: 
Novel therapeutics in prostate and bladder cancer
High dose vitamin D as a cancer therapeutic
Vitamin D insufficiency in cancer patients
Role of vitamin D supplementation in cancer prevention and morbidity reduction
Role of vitamin D in cancer prevention and treatment
Board Certification: 
Internal Medicine, American Board of Internal Medicine
Medical Oncology, American Board of Internal Medicine
Fellowship: 
Medical Oncology, Johns Hopkins Hospital, Baltimore, MD
Residency: 
Internal Medicine, Johns Hopkins Hospital, Baltimore, MD
Chief Resident, Osler Medical Service, Johns Hopkins Hospital, Baltimore, MD
Education and Training: 
MD - Johns Hopkins University School of Medicine, Baltimore, MD